Primary and secondary prevention of ischemic stroke;Prévention primaire et secondaire des accidents vasculaires ischémiques cérébraux

Journal Medical Libanais

Volumn 59, Issue 4, 2011, Pages 213-219

  Awada, Adnan ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; RAMIPRIL; TICLOPIDINE;

ANTIHYPERTENSIVE THERAPY; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; EXERCISE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; PRIMARY PREVENTION; REVIEW; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SMOKING CESSATION; METHODOLOGY; STROKE;

HUMANS; PRIMARY PREVENTION; RISK FACTORS; SECONDARY PREVENTION; STROKE;

EID: 84864880255     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. American Heart Association : Heart and Stroke Facts Statistics : 1997 statistical supplement, Dallas TX, USA, 1997.
2. Katzan IL, Furlan AJ, Llyod LE et al. Use of tissueplasminogen activator for acute ischemic stroke. The Cleveland area experience. JAMA 2000; 283 : 1151-8. (Pubitemid 30126603)
3. Wolf PA, Cobb JL, D'Agostino RB. Epidemiology of stroke. In : Barnett HJM et al. editors. Stroke, 2nd ed. New York : Churchill Livingstone, 1992 : 3-27.
4. MacMahon S, Rodgers A. The epidemiological association between blood pressure and stroke. Implications for primary and secondary prevention. Hypertension Research 1994; 17 (Suppl 1) : S23-S32. (Pubitemid 24195223)
5. Collins R, Peto P, MacMahon S et al. Blood pressure, stroke and coronary heart disease. Part 2 : Short-term reduction in blood pressure. Overview of randomized drug trials in the epidemiological context. Lancet 1990; 335 : 827-38. (Pubitemid 20113741)
6. SHEP Cooperative research group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program. JAMA 1991; 276 : 241-6.
7. Staessen JA, Fagard R, Thijs L et al. Randomised double blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial. Lancet 1997; 350 : 757-64. (Pubitemid 27387202)
8. Yusuf S, Sleight P, Pogue J et al. Effects of an angio-tensin- converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation (HOPE) study. N Engl J Med 2000; 342 : 145-53.
9. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction. A meta-analysis. Lancet 2001; 350 : 757-64.
10. Dahlof B, Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) : a randomized study against atenolol. Lancet 2002; 359 : 995-1003. (Pubitemid 34286536)
11. Chovanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42 : 1206-52. (Pubitemid 37553153)
12. UK prospective diabetes study group. Intensive bloodglucose control with metformin compared with conventional treatment and risk of complications in overweight patients with type 2 diabetes : UKPDS 34. Lancet 1998; 352 : 854-64.
13. Poulter NR. Blood pressure and glucose control in subjects with diabetes. New analysis from ADVANCE. J Hypertens 1995; 27 (suppl 1) : S3-S8.
14. Goldstein LB, Adams R, Albert MJ et al. Prevention of ischemic stroke. A Guideline from the American Heart Association & the American Stroke Association. Stroke 2006; 37 : 1583-633.
15. Schulz UG, Rothwell PM. Differences in vascular risk factors between etiological subtypes of ischemic strokes. Importance of population-based studies. Stroke 2003; 34 : 2050-9. (Pubitemid 36944805)
16. Scandinavian Simvastatin Survival Study (4S) Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994; 344 : 1383-9.
17. Shepherd J, Cobbe S, Ford E et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333 : 1301-7.
18. Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335 : 1001-9. (Pubitemid 26338729)
19. O'Reagan C, Wu P, Arora P et al. Statin therapy in stroke prevention : a meta-analysis of 121,000 patients. Am J Med 2008; 121 : 24-33.
20. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program. Adult treatment panel III guidelines. Arterioscler Thrombosis Vasc Biol 2004; 24 : e149-e161.
21. Wannamethee SG, Sharper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995; 274 : 155-60.
22. Sacco RL, Elkind M, Boden-Albala B et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281 : 53-60. (Pubitemid 29025100)
23. Dauchet L, Montaye M, Ruidavets JB et al. Association between the frequency of fruit and vegetable consumption and cardiovascular disease in male smokers and non-smokers. Eur J Clin Nutr 2010; 54 : 578-85.
24. Schwartz SM, Petitti DB, Siscivick DS et al. Stroke and use of low dose oral contraceptives in young women. A pooled analysis of two US studies. Stroke 1998; 29 : 2277-84. (Pubitemid 28511944)
25. Bath PM, Gray LJ. Association between hormone replacement therapy and subsequent stroke : A meta-analysis. BMJ 2005; 330 : 342-5.
26. Steering committee of the Physicians' Health Study research group. Final report on the on-going physicians healh study. N Engl J Med 1989; 321 : 129-35.
27. Manson JE, Stampfer MJ, Colditz GA et al. A prospective study of aspirine use and primary prevention of cardiovascular disease in women. JAMA 1991; 266 : 521-7.
28. Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352 : 1293-304.
29. Laupacis A, Albers G, Dalen J et al. Antithrombotic therapy in atrial fibrillation. Chest 1998; 114 : 579-89.
30. Petersen P, Boysen G, Goldtfredsen J et al. Placebocontrolled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1 : 175-9. (Pubitemid 19038801)
31. Boston area anticoagulation trial for atrial fibrillation investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323 : 1505-11.
32. Stroke prevention in atrial fibrillation investigators. Stroke prevention in atrial fibrillation study : final results. Circulation 1991; 84 : 527-39.
33. Connoly SJ, Laupacis A, Gent M et al. for the CAFA study investigators. Canadian atrial fibrillation anticoagulation study. J Am Coll Cardiol 1991; 18 : 349-55.
34. Ezekowitz MD, Bridges SL, James KE et al. for the veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992; 327 : 1406-12.
35. Hart RG, Sherman DG, Easton JD, Cairns JA. Prevention of stroke in patients with non-valvular atrial fibrillation. Neurology 1998; 51 : 674-81. (Pubitemid 28449242)
36. Benavente O, Moher D, Pham B. Carotid endarterectomy for asymptomatic carotid stenosis. A meta-analysis. BMJ 1998; 3117 : 1477-80. (Pubitemid 28532603)
37. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid artery stenting versus endarterectomy in high risk patients. N Engl J Med 2004; 351 : 1493-501.
38. Sacco RL, Shi T, Zamanilow MC et al. Predictors of mortality and recurrence after cerebral infarction. Neurology 1994; 44 : 626-34.
39. The individual data analysis of antihypertensive intervention trials (INDIANA) project collaborators. Effect of antihypertensive treatment in patients having already suffered from stroke : gathering the evidence. Stroke 1997; 28 : 2557-62.
40. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358: 1033-41.
41. Schrader J, Luders S, Kulschewski Aet al. Morbidity and mortality after stroke. Eprosartan compared with nitrenidipine for secondary prevention. Principal results of a prospective randomized controlled study (MOSES). Stroke 2005; 6 : 1218-26.
42. Plehn JF, Davis BR, Sacks FM et al. Reduction of stroke incidence after myocardial infarction with Pravastatin. The Cholesterol And Recurrent Events (CARE). Circulation 1999; 99 : 185-8.
43. Amarenco P, Bogousslavsky J, Callahan A et al. Stroke prevention by aggressive reduction in cholesterol levels (SPARCL). High dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355 : 549-59.
44. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med 1991; 325 : 445-53.
45. European Carotid Surgery Trialist Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis. Final results of the European Carotid Surgery Trial. Lancet 1998; 351 : 1379-87.
46. Mas JL, Chatellier G, Beyssen B, and the EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355 : 1660-71.
47. European atrial fibrillation trial study group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993; 342 : 1255-62.
48. CAPRIE steering committee. A randomized blinded trial of clopidogrel versus aspirin in patients with ischemic events. Lancet 1996; 384 : 1329-39.
49. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high risk patients (MATCH) : randomized, double blind, placebocontrolled trial. Lancet 2004; 364 : 331-7.
50. Diener HC, Cunha L, Forbes C et al. Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Scien 1966; 143 : 1-13.
51. Mohr JP, Thompson JL, Lazar RM et al. Acomparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345 : 1444-51.
52. Gorelick P. Stroke prevention therapy beyond antithrombotics : unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke 2002; 33 : 862-75. (Pubitemid 34204018)